Patient P-01874

Synthetic patientNBL-101 · Day 113 · 25–34 · M · baseline S18Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Deteriorating

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Improving

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S18

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity+6
GI instability-5
Nutritional resilience+5
Inflammatory activity-3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

10.6/100

improving · -5.6 vs previous 14 d

Toxicity

Blood

16.3/100

worsening · +13.4 vs previous 14 d

Sleep quality

Wearable

66.8/100

stable · +0.4 vs previous 14 d

Energy level

Daily log

7/10

stable · -0.1 vs previous 14 d

Stress level

Daily log

4.3/10

worsening · +0.2 vs previous 14 d

Steps

Wearable

7,071

stable · +199 vs previous 14 d

Adherence

Companion

93.7 %

stable · +2.1 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 96 from the failing basin, 10 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep histamine low
GI +3.1 next day on high-intake days · n 21
Keep alcohol low
GI +2.2 next day on high-intake days · n 16

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
+3.1detractor · 95%
Alcohol
+2.2detractor · 77%
Simple carbohydrates
+0.6no signal · 18%
Spicy / capsaicin
+0.5no signal · 16%
Dietary fat load
-0.1no signal · 15%
Insoluble fibre
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

FUT2 rs601338 AA (non-secretor)
Reduced mucosal fucosylation
CYP2D6 Rapid metabolizer
Expected exposure

Microbiome

Shannon diversity 3.6 · butyrate capacity 56/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 51 ms
Sleep: 7.9 h
Steps: 7,042
Resting HR: 56 bpm

Daily log: GI score 11, nutritional resilience 72, adherence 94.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01766	42%	S05	AD-05	no change	90
P-01804	28%	S19	AD-05	improved	61
P-01541	25%	S09	AD-05	no change	43
P-01329	45%	S08	BR-03	improved	79
P-01495	43%	S07	BR-03	improved	85
P-01677	39%	S05	BR-03	no change	86
P-01468	25%	S06	BR-03	no change	41
P-01654	45%	S08	CR-01	improved	85
P-01430	26%	S05	CR-01	improved	54
P-01479	38%	S15	DT-01	improved	84
P-01855	36%	S04	DT-01	improved	73
P-01724	31%	S10	DT-01	improved	63